Videos

Diagnosed with Stage III Inflammatory breast cancer in 2015, Jamie completed Living Beyond Breast Cancer’s Young Advocate Training in 2017, where she learned about research advocacy. Inspired by her son Luke, she continues to advocate for others as a way of giving back.

Nancy Herard-Marshall was a mother, former dancer/actress, teacher, therapist, and healer, who used her various life experiences to empower others, foster healing and create joy. Nancy passed away on May 26, 2024 and will be remembered for her important advocacy work and her ability to create community and connection.

Diagnosed with breast cancer at age 27, Anna Crollman turned her isolation into action, creating an online community to support young women facing adversity. Her community emphasizes vulnerability, self-confidence, and authenticity.

Gregory D. Garber, MSW, LCSW, is the administrative director of the Division of Supportive Oncology at the Sidney Kimmel Cancer Center (SKCC) at Jefferson Health. We are proud to honor Greg with our Founders Award for all that he has done and continues to do for the cancer community.

Amanda was diagnosed with a metastatic breast cancer recurrence in 2018. She and her husband had to find ways to help their young children adjust to her diagnosis and feel comfortable asking questions.

When Emily was diagnosed with early-stage breast cancer at age 35, she had to make decisions about when and how to tell her kids. She shares how she has navigated communication, including her daughter’s concerns about her own health.

In this short video, Dr. Pallav Mehta, assistance director of medicine at MD Anderson Cancer Center at Cooper, explains the many advantages and effectiveness of oral versus intravenous (IV) chemotherapy for breast cancer.

In this video, Dr. Pallav Mehta, associate professor of medicine at MD Anderson Cancer Center at Cooper, explains in easy-to-understand language, how novel antibody-drug conjugates, such as Trastuzumab deruxtecn (Enhertu), work to treat breast cancer.

Living Beyond Breast Cancer, Penn Medicine, and the Basser Center for BRCA held an important webinar on how to assess and understand your breast cancer risk, as well as learn about the risk-reducing surgical options for those who are at high risk for breast cancer or have BRCA1/2 gene mutations. Leading experts from Penn Medicine and the Basser Center for BRCA discussed and provided their insights on the latest in BRCA treatment, breast cancer risk evaluation and genetic counseling, risk-reducing mastectomy options, advancements in breast reconstruction after mastectomy, and post-surgical management and care.

If you have been diagnosed with estrogen receptor-positive, HER2-negative metastatic breast cancer you may develop an ESR1 mutation after progression on endocrine therapy. ESR1 mutation testing can help you and your healthcare team make decisions about the most effective treatment options for you. Eleonora Teplinksy, MD explains more about more about this test, who should get tested and when, and how it impacts treatments for metastatic breast cancer.

A diagnosis of estrogen-positive breast cancer at 54 reshaped Monica’s perspective, making exercise about movement and regaining control of her life. Recently, she’s been trying something new that fosters a shared experience with others who have been impacted by breast cancer. Meet all of the women in our BeACTive series.

Megan R, a marathon runner, is redefining her fitness expectations and finding a new joy in exercise during treatment for an early-stage breast cancer recurrence at 46. Meet all of the women in our BeACTive series.